A 12-year-old child with von Willebrand's disease is scheduled for a dental extraction. Which nursing intervention is most appropriate to prepare this child for the procedure?

Children with von Willebrand's disease have a bleeding disorder that requires specific preparation before surgical procedures. Desmopressin (DDAVP) is the treatment of choice to temporarily increase von Willebrand factor and Factor VIII levels, reducing bleeding risk during procedures.

Von Willebrand disease is the most common inherited bleeding disorder, affecting about 1% of the population. It is caused by a deficiency or dysfunction of von Willebrand factor (vWF), a protein essential for normal blood clotting. This leads to prolonged bleeding time and increased risk of bleeding during surgery.

When a child with von Willebrand disease needs a tooth extraction or other surgical procedure, the nurse's primary concern is preventing excessive bleeding. The most effective intervention is to collaborate with the physician to administer desmopressin (DDAVP) before the procedure. DDAVP is a synthetic analogue of antidiuretic hormone that stimulates the release of von Willebrand factor and Factor VIII from endothelial cells, temporarily improving hemostatic function.

The mechanism of action of DDAVP involves binding to V2 receptors on endothelial cells, triggering the release of stored vWF from Weibel-Palade bodies. This increases plasma levels of vWF and Factor VIII by 2 to 5 times baseline, significantly reducing the risk of bleeding during surgery. This effect typically lasts 6 to 8 hours, providing sufficient protection for most dental procedures.

Appropriate timing of DDAVP administration is critical—it should be given 30 to 60 minutes before the procedure to allow enough time for vWF levels to rise. Nurses must work closely with the healthcare team to ensure proper timing and dosage. Because the protective effect is temporary, monitoring for post-procedure bleeding complications remains essential.

This intervention represents evidence-based practice for perioperative management of von Willebrand disease and demonstrates the nurse's role in comprehensive care to minimize bleeding complications in pediatric patients with inherited bleeding disorders.

Understanding von Willebrand Disease and the Perioperative Challenge

When a child with von Willebrand disease (VWD) requires a dental extraction, the primary nursing concern is preventing excessive bleeding due to the underlying hemostatic defect. VWD is characterized by a quantitative or qualitative deficiency of von Willebrand factor (VWF), a protein crucial for platelet adhesion and aggregation at the site of vascular injury ^[1]. Without functional VWF, the formation of a stable platelet plug is impaired, turning a routine procedure like a dental extraction into a high-risk event for life-threatening hemorrhage ^[1]. The multidisciplinary management approach must therefore focus on prophylactically correcting this hemostatic abnormality before the surgical insult occurs ^[2].

Analyzing the Intervention Options

To determine the most appropriate nursing intervention, each option must be evaluated against the pathophysiological needs of a patient with a bleeding disorder.

- Option 1: Administer ibuprofen 30 minutes before the procedure. This is contraindicated. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that impairs platelet function by inhibiting cyclooxygenase, thereby reducing thromboxane A2 production. In a patient with an already compromised ability to form a platelet plug due to VWD, administering an antiplatelet medication would further increase the risk of severe intraoperative and postoperative bleeding.

- Option 2: Ensure the child fasts for 12 hours before the procedure. While fasting is a standard pre-anesthetic precaution to reduce aspiration risk, it does not address the unique, life-threatening risk of hemorrhage in a VWD patient. A prolonged fast in a child can also lead to dehydration and hypoglycemia, but more critically, it fails to provide any hemostatic benefit. Managing the bleeding diathesis is the priority.

- Option 3: Apply ice packs to the jaw area before the procedure. Ice application causes local vasoconstriction and can help reduce swelling and superficial bleeding after a procedure. However, applying it preoperatively will not prevent the profound intraoperative bleeding that occurs when tissues with a rich blood supply, like the gingiva and alveolar bone, are incised. This is a supportive measure, not a primary prophylactic strategy for a systemic coagulation disorder.

- Option 4: Coordinate with the physician to administer desmopressin (DDAVP) before the procedure. This is the correct and most appropriate intervention. Desmopressin (DDAVP) is a synthetic analog of vasopressin that stimulates the release of stored endogenous VWF and factor VIII (FVIII) from endothelial cells. For many patients with mild to moderate VWD (particularly Type 1), this transient rise in VWF and FVIII levels is sufficient to normalize hemostasis for a minor surgical challenge like a dental extraction . The nurse’s role in coordinating this therapy is critical, as the timing of administration is key to ensuring peak factor levels coincide with the procedure, thereby directly mitigating the risk of bleeding ^[2].

The Rationale for Prophylactic Hemostatic Support

The core principle in managing elective surgery for patients with inherited bleeding disorders is to perform a bleeding risk assessment and implement a targeted hemostatic management strategy before the procedure begins ^[2]. The systematic review of perioperative management confirms that for patients with established bleeding disorders, the goal is to correct the specific hemostatic defect ^[2]. In VWD, this means raising functional VWF levels. While recombinant VWF (rVWF) is an advanced therapeutic option that provides a full range of VWF multimers without the risk of pathogen transmission, DDAVP remains a first-line, non-invasive prophylactic agent for responsive patients undergoing minor procedures . Administering DDAVP directly addresses the pathophysiology of VWD by releasing the patient’s own stored VWF, thereby promoting platelet adhesion and preventing the severe bleeding that would otherwise occur during a dental extraction [1,4]. The nurse's coordination of this preoperative medication is the most critical safety intervention, as it bridges the gap between the patient’s baseline hemostatic deficiency and the surgical hemostatic challenge.